Patent dispute over EPO is still underway

In the recent patent dispute filed by Genetics Institute (GI) that Cheil Jedang's Epokine (erithropoietin), which was developed by the latter's own technology for the third time in the world, had infringed the former's patent on EPO, the Supreme Court reversed a patent court's ruling (No. 98-8243 dated December 15, 2000) and forwarded to the patent court.

Cheil Jedang plans to request the r...